Human MRC2 / CD280 Antibody (Quark patent anti-ENDO 180, Research Use)

产品名称	Human MRC2 / CD280 Antibody (Quark patent anti-ENDO 180, Research Use)
目录号	NBR-0823
别名	CD280; CLEC13E; ENDO180; KIAA0709
外观	Transparent Liquid
分子量	150kDa
CAS	N/A
溶解度	Water, PBS, TBS Buffer,etc.
存储条件	Temp. -80℃
保存时间	see COA
备注1	CHO Expressed
备注2	Ab. Isotype - IgG

目录号	规格	价格	库存状态
NBR-0823-100UG	100ug	￥550	请咨询
NBR-0823-1MG	1mg	￥3500	请咨询
NBR-0823-5MG	5mg	￥7500	请咨询

【产品概况】

产品名称：Human MRC2 / CD280 Antibody (Quark patent anti-ENDO 180, Research Use)
产品编号：NBR-0823
针对靶点：MRC2 / CD280
抗体药商品名：Quark patent anti-ENDO 180
抗体药描述：The drug is a recombinant fully human anti-ENDO 180 monoclonal antibody, being developed by Quark.

【产品参数】

产品外观：Transparent Liquid
分子量：~150kDa
CAS：N/A
溶解度：Water; PBS, TBS Buffer等
表达系统：CHO Expressed
抗体亚型：Ab. Isotype - IgG

【基因信息】

Gene Name: MRC2
Synonyms: CD280; CLEC13E; ENDO180; KIAA0709
Target Description: May play a role as endocytotic lectin receptor displaying calcium-dependent lectin activity. Internalizes glycosylated ligands from the extracellular space for release in an endosomal compartment via clathrin-mediated endocytosis.
Ensembl: ENSG00000011028
Uniprot: Q9UBG0